Literature DB >> 5420090

Nonspecific supersensitivity of the guinea-pig vas deferens produced by decentralization and reserpine treatment.

D P Westfall.   

Abstract

1. The sensitivity of the guinea-pig vas deferens to noradrenaline, histamine, methylfurmethide and potassium was examined in vitro following decentralization and reserpine treatment.2. One day after decentralization or administration of reserpine (1.0 mg/kg daily) the sensitivity of the vas deferens was not increased. After 5 days' treatment the muscle was supersensitive to all four stimulants.3. The magnitude of the sensitivity increase to an individual drug was the same following both chronic reserpine treatment and decentralization. However, the degree of supersensitivity differed for the four stimulants. The order of potentiation was noradrenaline>histamine>methylfurmethide>potassium.4. The magnitude of the supersensitivity was inversely correlated with the slope of the dose-response curves to the four agonists. The dose-response curve to potassium had the steepest slope, followed in order by methylfurmethide, histamine and noradrenaline.5. A hypothesis is presented to account for the inverse relationship between the slope of the dose-response curve and the degree of supersensitivity which follows reserpine treatment or decentralization.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5420090      PMCID: PMC1703014          DOI: 10.1111/j.1476-5381.1970.tb09560.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Sensitivity of the nictitating membrane after various procedures and agents.

Authors:  U TRENDELENBURG; N WEINER
Journal:  J Pharmacol Exp Ther       Date:  1962-05       Impact factor: 4.030

2.  Effect of reserpine and hypogastric denervation on the noradrenaline content of the vas deferens and the seminal vesicle of the guinea-pig.

Authors:  N O SJOSTRAND
Journal:  Acta Physiol Scand       Date:  1962 Nov-Dec

3.  Supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U TRENDELENBURG
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

4.  Supersensitivity following "pharmacological denervation".

Authors:  N EMMELIN
Journal:  Pharmacol Rev       Date:  1961-03       Impact factor: 25.468

5.  The development of supersensitivity to norepinephrine after pretreatment with reserpine.

Authors:  W W FLEMING; U TRENDELENBURG
Journal:  J Pharmacol Exp Ther       Date:  1961-07       Impact factor: 4.030

6.  A relatively nonspecific supersensitivity in aortic strips resulting from pretreatment with reserpine.

Authors:  P M Hudgins; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

7.  Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium.

Authors:  P M Hudgins; G B Weiss
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

8.  The effect of decentralization and reserpine-treatment on the sensitivity of the isolated vas deferens of the guinea-pig to stimulant drugs.

Authors:  D P Westfall
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

9.  The sensitivity of the guinea-pig pacemaker to norepinephrine and calcium after pretreatment with reserpine.

Authors:  D P Westfall; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1968-12       Impact factor: 4.030

10.  Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U Trendelenburg
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

View more
  13 in total

1.  Dual effect of alpha-adrenoceptor antagonists in rat isolated vas deferens.

Authors:  A Jurkiewicz; N H Jurkiewicz
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

2.  Inhibition of sympathetic transmission in rat heart by clonidine: the roles of stimulation frequency, endogenous feedback and noradrenaline re-uptake.

Authors:  J R Docherty; J C McGrath
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

3.  The role of supersensitivity to acetyl- choline in the production of tolerance to morphine in stimulated guinea-pig ileum.

Authors:  S Shoham; M Weinstock
Journal:  Br J Pharmacol       Date:  1974-12       Impact factor: 8.739

4.  The effect of reserpine treatment and decentralization on the ion distribution in the vas deferens of the guinea-pig.

Authors:  D P Westfall
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

5.  Analysis of the effects of dopamine and noradrenaline in relation to the proposed postsynaptic dopamine receptor in rat vas deferens.

Authors:  A Langeloh; A Jurkiewicz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

6.  Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs.

Authors:  N Ambache; L P Dunk; J Verney; M A Zar
Journal:  J Physiol       Date:  1972-12       Impact factor: 5.182

Review 7.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

8.  Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens.

Authors:  P Sneddon; D P Westfall
Journal:  J Physiol       Date:  1984-02       Impact factor: 5.182

9.  The effects of drugs on the sensitivity of the rat anococcygeus muscle to agonists.

Authors:  A Gibson; D Pollock
Journal:  Br J Pharmacol       Date:  1973-11       Impact factor: 8.739

10.  Supersensitivity of cortical neurones of the rat to acetylcholine and L-glutamate following chronic morphine treatment.

Authors:  M Satoh; W Zieglgänsberger; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.